ME Therapeutics Holdings, Inc. (TSE:METX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ME Therapeutics Holdings Inc., a biotech firm specializing in Immuno-Oncology, has announced a non-brokered private placement aimed at raising $1.55 million. The funds are planned to support the company’s research and development, regulatory processes, and general operating needs. The private placement comprises units priced at $1.00, with each unit including a share and a warrant, potentially accelerating if certain trading conditions are met.
For further insights into TSE:METX stock, check out TipRanks’ Stock Analysis page.